Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)
Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)
Enrolling by invitation · NCT05579626 · Registry updated 2026-01-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM) | Nutritional and Metabolic Diseases, glucose intolerance, glucose metabolism disease, hyperglycemia, metabolic disease | Enrolling by invitation | Phase 4 | 2026-01-07 | NCT05579626 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Seung-Whan Lee, M.D., Ph.D. | 3 |
| Yuhan Corporation | 14 |
31 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.